Drugs & Medical Devices
Get ready for the next wave of pharmaceutical litigation with HarrisMartin's Drugs & Medical Devices. This reporter will keep you one step ahead of drug and medical device litigation with in-depth investigations, guest commentaries and objective courtroom coverage on today's and tomorrow's hottest drugs and supplements.
SEARCH THE ARCHIVES
Issue #4, April 2002
Plaintiffs in an OxyContin case have filed a motion seeking a temporary restraining order to prevent Purdue Pharma from utilizing two U.S. attorneys and a law enforcement officer as consultants
According to a March 14 decision by the U.S. District Court for the Western District of Virginia, it is not necessary to determine class certification under Federal Rule of Civil Procedure 23 before allowing the plaintiffs to withdraw their class action a
The family of a woman who died after taking the dietary supplement Lipokinetix has sued the product's manufacturers and the fitness center where she bought the supplement, claiming they were aware it was dangerous and could cause fatal liver injuries
Plaintiff co-lead counsel Charles S. "Bucky" Zimmerman of Zimmerman Reed and Richard A. Lockridge of Lockridge Grindal Nauen, P.L.L.P., both in Minneapolis, spoke with HarrisMartin Publishing about where the Baycol MDL currently stands.
Defendants in MDL 1355 have filed their response to plaintiffs' master class action preliminary trial plan, in which they detail several reasons as to how the trial plan is inadequate
A lawsuit filed against Eli Lilly in federal district court in Washington alleges that the plaintiff's birth defects were caused by her mother's ingestion of the drug DES
A lawsuit has been filed in California state court against the makers of the cholesterol-lowering drug Baycol, contending that the companies
Despite plaintiffs' attempt to withdraw the motion, a federal court in Kentucky has denied class certification to plaintiffs
An initial case management order has been entered in the recently consolidated Baycol proceedings in Philadelphia
Following a February liaison counsel conference, a case management order concerning medical causation testimony and